PET in oncology: Will it replace the other modalities?
References (85)
- et al.
Whole-body positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose can detect recurrent ovarian carcinoma
Gyn Onc
(1993) - et al.
Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management
Chest
(1993) - et al.
Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET)
J Thorac Cardiovasc Surg
(1995) - et al.
Evaluation of pulmonary lesions with FDG-PET. Comparison of findings in patients with and without a history of prior malignancy
Chest
(1996) - et al.
PET-FDG imaging and transthoracic needle lung aspiration biopsy in evaluation of pulmonary lesions. A comparative risk-benefit analysis
Chest
(1995) - et al.
Contribution of PET in the diagnosis of recurrent colorectal cancer: Comparison with conventional imaging
Eur J Surg Oncol
(1995) - et al.
Metabolic imaging of untreated prostate cancer by positron emission tomography with 18fluorine-labeled deoxy-glucose
J Urol
(1996) - et al.
Experience with positron emission tomography (PET) scans in patients with ovarian cancer
Gyn Onc
(1994) - et al.
Assessment of primary and metastatic ovarian cancer by positron emission tomography (PET) using 2-[18F]deoxy-glucose (2-[18F]FDG
Gyn Onc
(1993) - et al.
Glucose utilization of cerebral gliomas measured by 18F-fluorodeoxyglucose and PET
Neurology
(1982)
Glycolytic rate and histological grade of human cerebral gliomas: a study with 18F-fluorodeoxyglucose and positron emission tomography
Glucose utilization by intracranial meningiomas as an index of tumor aggressivity and probability of recurrence: A PET study
Radiology
(1987)
Positron emission tomography using [18F]fluorodeoxyglucose in brain tumors — A powerful diagnostic and prognostic tool
Invest Radiol
(1987)
Cerebral necrosis after radiotherapy and/or intra-arterial chemotherapy for brain tumors: PET and neuropathologic studies
AJR
(1988)
On the origins of cancer cells
Science
(1956)
Assessment of response to cancer therapy using fluorine-18-fluorodeoxyglucose and positron emission tomography
J Nucl Med
(1991)
Determination of malignancy of thyroid nodules with positron emission tomography
Surgery
(1993)
Uptake of 18-fluoro-2-deoxy-D-glucose by thyroid cancer: Implications for diagnosis and therapy
J Clin Endocrinol Metab
(1993)
Positron emission tomography of thyroid masses
Thyroid
(1993)
Positron emission tomographic scanning of primary and metastatic breast with the radiolabeled glucose analogue 2-deoxy-2[18F]fluoro-D-glucose
N Engl J Med
(1991)
Primary and metastatic breast carcinoma: Initial clinical evaluation with PET with the radiolabeled glucose analogue-2-[F-18]-Fluoro-2-deoxy-D-glucose
Radiology
(1991)
The application of positron emission tomographic imaging with fluorodeoxyglucose to the evaluation of breast disease
Ann Surg
(1992)
Evaluation of breast masses and axillary lymph nodes with [F-18] 2-deoxy-2-fluoro-D-glucose PET
Radiology
(1993)
Positron emission tomography with fluorine-18-deoxy-glucose in the detection and staging of breast cancer
Cancer
(1993)
Comparison of fluorine-18-2 fluorodeoxyglucose and gallium 67 citrate imaging for detection of lymphoma
J Nucl Med
(1987)
The use of FDG-PET in the detection and management of malignant lymphoma: Correlation of uptake with prognosis
J Nucl Med
(1991)
Uptake of carbon-11-methionine and fluorodeoxyglucose in non-Hodgkin's lymphoma: A PET study
J Nucl Med
(1991)
Positron emission tomography using fluorine-18-fluorodeoxyglucose in malignant lymphoma: a comparison with proliferative activity
J Nucl Med
(1992)
Imaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose: Correlation with CT
Radiology
(1994)
Glucose utilization in vivo by human pulmonary neoplasms
Cancer
(1987)
Differential diagnosis of lung tumor with positron emission tomography: A prospective study
J Nucl Med
(1990)
Solitary pulmonary nodules: detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose
Radiology
(1992)
Focal pulmonary abnormalities: Evaluation with F-18 fluorodeoxyglucose PET scanning
Radiology
(1993)
Lung tumor metastasis to breast detected by fluorine-18-fluorodeoxyglucose PET
J Nucl Med
(1993)
Imaging of pulmonary mass lesions with whole-body positron emission tomography and fluorodeoxyglucose
Cancer
(1993)
Satellite PET and lung cancer: A prospective study in surgical patients
Nuc Med Commun
(1993)
Glucose uptake, perfusion, and cell proliferation in head and neck tumors: Relation of positron emission tomography to flow cytometry
J Nucl Med
(1991)
Positron emission tomography: A new precise imaging modality for detection of primary head and neck tumors and assessment of cervical adenopathy
Laryngoscope
(1992)
Change induced by radiation therapy in FDG uptake in normal and malignant structures of the head and neck: quantitation with PET
Radiology
(1993)
The relevance of positron emission tomography for the diagnosis and treatment of head and neck tumors
J Otolaryng
(1993)
Fluorodeoxyglucose imaging of advanced head and neck cancer after chemotherapy
J Nucl Med
(1993)
Cited by (0)
Copyright © 1997 Published by Elsevier Inc.